Doctors across the country, including UT Health San Antonio physicians, are hopeful that convalescent plasma can now be used as an effective therapy in the fight against the coronavirus.
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 and is being studied in clinical trials at University Hospital.
It’s important for the public to keep their cancer screenings, tests and treatments during this time. In this pre-recorded message, Ruben Mesa, M.D., FACP, explains that the Mays Cancer Center is open and safe for patients.
Grace Notes community choir is virtually connecting people living with dementia and their families through the healing power of music.
Check out UT Health San Antonio's response in the battle against COVID-19 and the stories that inspire us.
Leave a note of encouragement and support for all staff and providers at UT Health San Antonio.
Learn more about the UT Health San Antonio COVID-19 Response Fund.
Texas Public Radio: Pregnant in a pandemic: How to protect yourself and baby from COVID-19
Rivard Report: Health care providers resume doctor visits, surgeries as restrictions lift
KSAT 12: San Antonio doctor involved in remdesivir trial says FDA emergency approval is ‘very exciting’
Other faculty experts in the media